Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Swearingen

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Pediatric Cardiology|September 4, 2013
Academic proficiency in children after early congenital heart disease surgerySarah B Mulkey, Christopher J Swearingen, Maria S Melguizo, et al.
Pediatric Cardiology|May 9, 2013
Multi-tiered analysis of brain injury in neonates with congenital heart diseaseSarah B Mulkey, Christopher J Swearingen, Maria S Melguizo, et al.
Pediatric Neurology|August 28, 2014
White matter injury in newborns with congenital heart disease: a diffusion tensor imaging studySarah B Mulkey, Xiawei Ou, Raghu H Ramakrishnaiah, et al.
Modern Rheumatology|July 4, 2012
Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet's syndrome for patients in the US and Japan: data from a large, three-center cohort studyTatsuo Kobayashi, Mitsumasa Kishimoto, Christopher J Swearingen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2020
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized TrialYusuf Yazici, Timothy E McAlindon, Allan Gibofsky, et al.
Journal of Pediatric Surgery|December 10, 2013
Persistent gastrocutaneous fistula: factors affecting the need for closureDeidre L Wyrick, Andrew P Bozeman, Samuel D Smith, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|August 16, 2013
Promoting use of booster seats in rural areas through community sports programsMary E Aitken, Beverly K Miller, Byron L Anderson, et al.
Osteoarthritis and Cartilage Open|October 6, 2025
Biochemical biomarkers of knee osteoarthritis progression: Results from the FNIH biomarkers consortium progress OA studyJamie E Collins, Douglas Robinson, Nigel Arden, et al.
Osteoarthritis and Cartilage|February 15, 2021
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritisY Yazici, T E McAlindon, A Gibofsky, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 12, 2025
Assessing Rheumatoid Arthritis Disease Activity Measures in Ethnic Minority Patients in the United States: Real-World Data From the Ethnic Minority Rheumatoid Arthritis Consortium RegistryMercedes Quiñones, Sharon Dowell, Rodolfo Perez Alamino, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Pediatric Cardiology|September 4, 2013
Academic proficiency in children after early congenital heart disease surgerySarah B Mulkey, Christopher J Swearingen, Maria S Melguizo, et al.
Pediatric Cardiology|May 9, 2013
Multi-tiered analysis of brain injury in neonates with congenital heart diseaseSarah B Mulkey, Christopher J Swearingen, Maria S Melguizo, et al.
Pediatric Neurology|August 28, 2014
White matter injury in newborns with congenital heart disease: a diffusion tensor imaging studySarah B Mulkey, Xiawei Ou, Raghu H Ramakrishnaiah, et al.
Modern Rheumatology|July 4, 2012
Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet's syndrome for patients in the US and Japan: data from a large, three-center cohort studyTatsuo Kobayashi, Mitsumasa Kishimoto, Christopher J Swearingen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2020
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized TrialYusuf Yazici, Timothy E McAlindon, Allan Gibofsky, et al.
Journal of Pediatric Surgery|December 10, 2013
Persistent gastrocutaneous fistula: factors affecting the need for closureDeidre L Wyrick, Andrew P Bozeman, Samuel D Smith, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|August 16, 2013
Promoting use of booster seats in rural areas through community sports programsMary E Aitken, Beverly K Miller, Byron L Anderson, et al.
Osteoarthritis and Cartilage Open|October 6, 2025
Biochemical biomarkers of knee osteoarthritis progression: Results from the FNIH biomarkers consortium progress OA studyJamie E Collins, Douglas Robinson, Nigel Arden, et al.
Osteoarthritis and Cartilage|February 15, 2021
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritisY Yazici, T E McAlindon, A Gibofsky, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 12, 2025
Assessing Rheumatoid Arthritis Disease Activity Measures in Ethnic Minority Patients in the United States: Real-World Data From the Ethnic Minority Rheumatoid Arthritis Consortium RegistryMercedes Quiñones, Sharon Dowell, Rodolfo Perez Alamino, et al.
Pageof 8